NasdaqGS:CLOVHealthcare
Court Win Lifts Clover Health Star Rating And Future Revenue Potential
Clover Health Investments (NasdaqGS:CLOV) secured a court ruling requiring the Centers for Medicare & Medicaid Services to recalculate its 2026 Medicare Star Rating.
The US District Court decision results in an upgrade for Clover Health's main PPO plan from 3.5 to 4.5 stars.
The higher rating is expected to increase future CMS bonus payments tied to that plan's performance.
The ruling reverses a prior downgrade and strengthens Clover Health's position within the Medicare Advantage...